Skip to content

IDW Pharma

Active
Private limited companyfounded 20251 yr activeWouters-Lefebvreplein 35A, 2830 Willebroek, BelgiumKBO/BCE: BE 1019.869.579
Summary

IDW Pharma has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €46,772 and a net result of €41,772. Its solvency ranks better than 70% of 7794 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Checked score

Score 2025
Axes
Profitability100
Solvency97
Growth-
Track record67
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4,000 at 30 days acceptable
Liquidity ample (current ratio 3.58; short-term debt: 28% and cash: 70.9% of total assets), and 28% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 82
Relative position
BE, all sectors
reference
Office administrative, office support and other business support activities (NACE 82)
about 37% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
72%
Return on assets
64.3%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
18 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

IDW Pharma was incorporated on 11 February 2025 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€46,772
Total assets
€64,918
Net result
€41,772
Working capital
€46,772

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Equity and liabilities €64,918
Equity €46,772
Debt €18,146
Debt finances 28.0% of the balance-sheet total.
Key figures and ratios
2025 value
Current ratio
3.58
Debt to equity
0.39
ROE
89.3%
ROA
64.3%
Debt ≤ 1 year
€18,146
Income taxes
€11,480

Peer companies

Historical observation

Of the 11,279 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.5% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,279 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 29 lines
Balance sheet Code2025
Assets
Total assets20/58€64,918
Current assets29/58€64,918
Amounts receivable within one year40/41€18,909
Trade receivables40€18,909
Cash at bank and in hand54/58€46,010
Equity and liabilities
Total equity and liabilities10/49€64,918
Equity10/15€46,772
Contributions10/11€5,000
Reserves13€41,772
Distributable reserves133€41,772
Amounts payable17/49€18,146
Amounts payable within one year42/48€18,146
Trade debts44€515
Suppliers440/4€515
Taxes, remuneration and social security45€17,375
Taxes450/3€17,375
Other amounts payable47/48€256
Income statement Code2025
Other operating charges640/8€1,393
Gross operating margin9900€54,757
Operating profit (loss)9901€53,364
Financial charges65/66B€112
Recurring financial charges65€112
Profit (loss) for the period before taxes9903€53,252
Income taxes67/77€11,480
Profit (loss) for the period9904€41,772
Profit (loss) for the period to be appropriated9905€41,772
Appropriation of the result
Profit (loss) to be appropriated9906€41,772
Transfer to equity691/2€41,772
To other reserves6921€41,772

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Other operating charges640/8€1,393
Gross operating margin9900€54,757
Operating profit (loss)9901€53,364
Financial charges65/66B€112
Recurring financial charges65€112
Profit (loss) for the period before taxes9903€53,252
Income taxes67/77€11,480
Profit (loss) for the period9904€41,772
Profit (loss) for the period to be appropriated9905€41,772
Line2025
Assets
Total assets20/58€64,918
Current assets29/58€64,918
Amounts receivable within one year40/41€18,909
Trade receivables40€18,909
Cash at bank and in hand54/58€46,010
Equity and liabilities
Total equity and liabilities10/49€64,918
Equity10/15€46,772
Contributions10/11€5,000
Reserves13€41,772
Distributable reserves133€41,772
Amounts payable17/49€18,146
Amounts payable within one year42/48€18,146
Trade debts44€515
Suppliers440/4€515
Taxes, remuneration and social security45€17,375
Taxes450/3€17,375
Other amounts payable47/48€256
Line2025
Profit (loss) for the period9904€41,772
Operating cash flow (approximation)€41,772

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
18-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 18 days late
NBB filing
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Willebroek · 1 establishment unit since 2025
seat establishment The establishment unit on the map
Ground area
1,322 m²
Building footprint
108 m²
Volume, LiDAR
714 m³
Parcel 12004B0230/00K000, Flanders · tallest building 9.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
IDW Pharma
Wouters-Lefebvreplein 35A, 2830 WillebroekOther business support services
since 20252.369.989.419
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12004B0230/00K000 Flanders 1,322 m² 1 · 108 m² 9.7 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 24,517 companies in sector 82990 we hold annual accounts for 9,415. 6,871 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded11-02-2025
Fiscal year end31-12
Activities, NACEBEL 2025
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:1019869579
Also 9925:BE1019869579
Registered 23-11-2025

Register as of 26 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.